Download presentation
Presentation is loading. Please wait.
Published byCamron Short Modified over 5 years ago
1
Survival After Surgery for Pathologic Stage IA Non-Small Cell Lung Cancer Associated With Idiopathic Pulmonary Fibrosis Yuichi Saito, MD, Yasuyuki Kawai, MD, Nobumasa Takahashi, MD, PhD, Tomohiko Ikeya, MD, PhD, Katsumi Murai, MD, PhD, Yoshinori Kawabata, MD, PhD, Eishin Hoshi, MD, PhD The Annals of Thoracic Surgery Volume 92, Issue 5, Pages (November 2011) DOI: /j.athoracsur Copyright © Terms and Conditions
2
Fig 1 Overall 5-year survival in patients with pathologic stage IA non-small cell lung cancer was 54.2% for the 28 patients with idiopathic pulmonary fibrosis (IPF, dashed line) and 88.3% for the 322 patients without IPF (solid line). The median follow-up was 4.20 years for IPF patients and 4.95 years for non-IPF patients. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © Terms and Conditions
3
Fig 2 Overall 6-year survival in 28 patients, matched by propensity score, with pathologic stage IA non-small cell lung cancer was 54.2% in the patients with idiopathic pulmonary fibrosis (IPF; dashed line) and 82.6% for the patients without IPF (solid line). The median follow-up was 4.20 years for IPF patients and 4.15 years for non-IPF patients group. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.